BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rupp C, Rössler A, Zhou T, Rauber C, Friedrich K, Wannhoff A, Weiss KH, Sauer P, Schirmacher P, Süsal C, Stremmel W, Gotthardt DN. Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis. United European Gastroenterol J 2018;6:255-62. [PMID: 29511555 DOI: 10.1177/2050640617717156] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Invernizzi F, Cilla M, Trapani S, Guarino M, Cossiga V, Gambato M, Morelli MC, Morisco F, Burra P, Floreani A. Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice. JPM 2022;12:925. [DOI: 10.3390/jpm12060925] [Reference Citation Analysis]
2 Attauabi M, Wewer MD, Bendtsen F, Seidelin JB, Burisch J. Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis. Inflamm Bowel Dis 2022:izac003. [PMID: 35134921 DOI: 10.1093/ibd/izac003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tica S, Alghamdi S, Tait C, Nemera B, Turmelle Y, Fleckenstein J, Stoll J, Kulkarni S. Diagnosis of Primary Sclerosing Cholangitis Beyond Childhood is Associated with Worse Outcomes. Journal of Clinical and Experimental Hepatology 2022;12:110-7. [DOI: 10.1016/j.jceh.2021.03.006] [Reference Citation Analysis]
4 Berenguer M, Di Maira T, Baumann U, Mirza DF, Heneghan MA, Klempnauer JL, Bennet W, Ericzon B, Line P, Lodge PA, Zieniewicz K, Watson CJE, Metselaar HJ, Adam R, Karam V, Aguilera V. Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry. Transplantation 2021;105:2255-62. [DOI: 10.1097/tp.0000000000003542] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cortez RV, Moreira LN, Padilha M, Bibas MD, Toma RK, Porta G, Taddei CR. Gut Microbiome of Children and Adolescents With Primary Sclerosing Cholangitis in Association With Ulcerative Colitis. Front Immunol 2020;11:598152. [PMID: 33613519 DOI: 10.3389/fimmu.2020.598152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Trivedi PJ, Crothers H, Mytton J, Bosch S, Iqbal T, Ferguson J, Hirschfield GM. Effects of Primary Sclerosing Cholangitis on Risks of Cancer and Death in People With Inflammatory Bowel Disease, Based on Sex, Race, and Age. Gastroenterology 2020;159:915-28. [PMID: 32445859 DOI: 10.1053/j.gastro.2020.05.049] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
7 Hippchen T, Sauer P, Göppert B, Schirmacher P, Gotthardt DN, Weiss KH, Stremmel W, Rupp C. Association between serum IgG level and clinical course in primary sclerosing cholangitis. BMC Gastroenterol 2019;19:153. [PMID: 31455255 DOI: 10.1186/s12876-019-1075-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Wannhoff A, Gotthardt DN. Recent developments in the research on biomarkers of cholangiocarcinoma in primary sclerosing cholangitis. Clin Res Hepatol Gastroenterol. 2018;pii:S2210-7401(18)30177-3. [PMID: 30266579 DOI: 10.1016/j.clinre.2018.08.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
9 Virani S, Akers A, Stephenson K, Smith S, Kennedy L, Alpini G, Francis H. Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma. J Liver 2018;7:231. [PMID: 30613437 DOI: 10.4172/2167-0889.1000231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Bechstein WO, Schnitzbauer AA. Prognosis of primary sclerosing cholangitis - time to look at the population as a whole, not only from the center's or waiting list perspective. Transpl Int 2018;31:585-7. [PMID: 29603453 DOI: 10.1111/tri.13158] [Reference Citation Analysis]